Antagonism between PTEN/MMAC1/TEP-1 and androgen receptor in growth and apoptosis of prostatic cancer cells

被引:81
作者
Li, PF
Nicosia, SV
Bai, WL
机构
[1] Univ S Florida, Coll Med, Dept Pathol, Tampa, FL 33612 USA
[2] Univ S Florida, H Lee Moffitt Canc Ctr, Program Mol Oncol & Drug Discovery, Tampa, FL 33612 USA
关键词
D O I
10.1074/jbc.M010226200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
PTEN/MMAC1/TEP-1 (PTEN) tumor suppressor and androgen receptor play important roles in prostatic tumorigenesis by exerting opposite effects on homeostasis of prostatic epithelium. Here, we describe a mutual repression and selective dominance between PTEN and the androgen receptor (AR) in the growth and the apoptosis of prostatic cancer cells. On the one hand, PTEN and an inhibitor of phosphoinositide 3-kinase repressed the transcriptional activity of the AR as well as androgen-induced cell proliferation and production of prostate-specific antigen. On the other hand, androgens protected prostate cancer cells from PTEN-induced apoptosis in an AR-dependent manner. Whereas the repression of the transcriptional activity of the AR by PTEN is likely to involve the down-regulation of AKT, androgens protected prostate cancer cells from PTEN-induced apoptosis without an effect on AKT activity, demonstrating a differential involvement of AKT in the interaction between PTEN and the AR. Our data suggest that the loss of PTEN function may induce tumorigenesis through unopposed activity of the AR as well as contribute to the resistance of prostate cancers to androgen ablation therapy.
引用
收藏
页码:20444 / 20450
页数:7
相关论文
共 37 条
[21]   Proteasome-dependent degradation of the human estrogen receptor [J].
Nawaz, Z ;
Lonard, DM ;
Dennis, AP ;
Smith, CL ;
O'Malley, BW .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (05) :1858-1862
[22]   Activation of the human androgen receptor through a protein kinase A signaling pathway [J].
Nazareth, LV ;
Weigel, NL .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (33) :19900-19907
[23]  
ONATE SA, 1995, SCIENCE, V270, P1354
[24]   Regulation of G1 progression by the PTEN tumor suppressor protein is linked to inhibition of the phosphatidylinositol 3-kinase/Akt pathway [J].
Ramaswamy, S ;
Nakamura, N ;
Vazquez, F ;
Batt, DB ;
Perera, S ;
Roberts, TM ;
Sellers, WR .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (05) :2110-2115
[25]  
Snoek R, 1998, PROSTATE, V36, P256
[26]   Negative regulation of PKB/Akt-dependent cell survival by the tumor suppressor PTEN [J].
Stambolic, V ;
Suzuki, A ;
de la Pompa, JL ;
Brothers, GM ;
Mirtsos, C ;
Sasaki, T ;
Ruland, J ;
Penninger, JM ;
Siderovski, DP ;
Mak, TW .
CELL, 1998, 95 (01) :29-39
[27]   Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers [J].
Steck, PA ;
Pershouse, MA ;
Jasser, SA ;
Yung, WKA ;
Lin, H ;
Ligon, AH ;
Langford, LA ;
Baumgard, ML ;
Hattier, T ;
Davis, T ;
Frye, C ;
Hu, R ;
Swedlund, B ;
Teng, DHF ;
Tavtigian, SV .
NATURE GENETICS, 1997, 15 (04) :356-362
[28]   PTEN modulates cell cycle progression and cell survival by regulating phosphatidylinositol 3,4,5,-trisphosphate and Akt protein kinase B signaling pathway [J].
Sun, H ;
Lesche, R ;
Li, DM ;
Liliental, J ;
Zhang, H ;
Gao, J ;
Gavrilova, N ;
Mueller, B ;
Liu, X ;
Wu, H .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (11) :6199-6204
[29]   High cancer susceptibility and embryonic lethality associated with mutation of the PTEN tumor suppressor gene in mice [J].
Suzuki, A ;
de la Pompa, JL ;
Stambolic, V ;
Elia, AJ ;
Sasaki, T ;
Barrantes, ID ;
Ho, A ;
Wakeham, A ;
Itie, A ;
Khoo, W ;
Fukumoto, M ;
Mak, TW .
CURRENT BIOLOGY, 1998, 8 (21) :1169-1178
[30]   Inhibition of cell migration, spreading, and focal adhesions by tumor suppressor PTEN [J].
Tamura, M ;
Gu, JG ;
Matsumoto, K ;
Aota, S ;
Parsons, R ;
Yamada, KM .
SCIENCE, 1998, 280 (5369) :1614-1617